Jason Patten Appointed to iRhythm Holdings Board
Jason Patten, with extensive experience in healthcare strategy and leadership, has been appointed to the Board of Directors of iRhythm Holdings, effective March 12, 2026.
San Francisco, Calif. – iRhythm Holdings, Inc. (NASDAQ: IRTC), a digital health care company, announced the appointment of Jason Patten to its Board of Directors, effective March 12, 2026. Patten brings decades of strategic leadership experience in the healthcare sector.
The appointment is intended to bolster iRhythm's focus on innovation and long-term growth. "Jason’s deep experience leading enterprise strategy, innovation, and strategic partnerships at one of the world’s largest healthcare organizations will be invaluable," said Chairman of the Board Abhi Talwalkar. Talwalkar highlighted Patten's potential contribution as iRhythm expands into primary care and enhances its AI and workflow capabilities.
Patten currently serves as Executive Vice President and Head of Enterprise Strategy at UnitedHealth Group. Previously, he held leadership roles within OptumHealth and has experience in financial services and marketing, including global product development and strategic marketing.
iRhythm Holdings focuses on creating solutions that detect, predict, and prevent disease. The company combines wearable biosensors and cloud-based data analytics with proprietary algorithms to distill heart rhythm data into clinically actionable information.